Top

International Journal of Bipolar Disorders

Published in:

Open Access 01-12-2024 | Review

Lithium: current state of the art and future directions

Authors: Michael Gitlin, Michael Bauer

Published in: International Journal of Bipolar Disorders | Issue 1/2024

Abstract

Background

Lithium is our oldest continuously prescribed medication in psychopharmacology, with its history as an agent for treating mood disorders extending from the 19th century. Although clinicians prescribe it less frequently than in the past, its utility in treating bipolar disorder is unquestionable. Novel potential indications for its use in psychiatry have created excitement about broader roles for lithium in treating and preventing other disorders.

Content

Lithium is effective both in treating acute mania, as an adjunctive antidepressant, and as a maintenance treatment in bipolar disorder. Lithium has also shown some efficacy in treating and preventing unipolar depression, but less clearly than for bipolar maintenance treatment and acute mania. Common side effects include nausea, polyuria, tremor, weight gain and cognitive dulling. These side effects are typically manageable with reasonable clinical strategies. Lithium affects renal, thyroid and parathyroid function. With clinical monitoring, these effects are easily managed although infrequent cases of severe renal insufficiency may occur with long term use. Although not all studies are positive, a consistent database suggests the efficacy of lithium in decreasing suicide attempts and suicides, likely due to its effect on impulsivity and aggression as well as its prophylaxis against depressive and manic recurrences. Recent data have suggested lithium’s potential efficacy for a number of new clinical indications. Lithium’s neuroprotective effects suggest potential efficacy in preventing mild cognitive impairment (MCI) and dementia as well as in aiding recovery from strokes. Higher (but still trace) lithium levels in drinking water are associated with lower rates of dementia. It is still not clear how much lithium-and what serum lithium levels- are required for either of these effects. Other preliminary research suggests that lithium may also have antiviral effects and may decrease cancer risk.

Conclusions

Lithium continues to be the mainstay treatment of mood disorders in general and in bipolar disorder specifically. Other potential clinical uses for lithium in psychiatry have re-invigorated excitement for research in other areas such as suicide, preventing cognitive impairment and possibly preventing viral infections and diminishing cancer risk.

Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible Lithium-effectuated neurotoxicity. Clin Neuropharmacol. 2005;28(1):38–49.PubMedCrossRef

Aiff H, Attman P, Aurell M, Bendz H, Schӧn S, Svedlund J. End-stage renal disease associated with prophylactic lithium treatment. European Neuropsychopharmacology. 2014;24:540–4.

Aiff H, Attman P, Aurell M, et al. Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol. 2015. https://doi.org/10.1177/0269881115573808).CrossRefPubMed

Albert U, De Cori D, Aguglia A, et al. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study. J Affect Disord. 2013;151:786–90.PubMedCrossRef

Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry. 2015;20:661–70.PubMedPubMedCentralCrossRef

Amdisen A. Monitoring of lithium treatment through determination of lithium concentration. Dan Med Bull. 1975;22:277–90.PubMed

Anmella G, Fico G, Lotfaliany M, et al. Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses. Neurosci Biobehav Rev. 2021;126:529–41.PubMedCrossRef

Araldi E, Jutzeler CR, Ristow M. Lithium treatment extends human lifespan: findings from the UK Biobank. Aging. 2023;15(2):421–40.PubMedPubMedCentralCrossRef

Baastrup PC, Schou M. Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry. 1967;16:162–72.PubMedCrossRef

Baastrup PC. The use of lithium in manic-depressive psychosis. Compr Psychiatry. 1964;5(6):396–408.PubMedCrossRef

Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM. Lithium poisoning. J Intensive Care Med. 2016;32:249–63. https://doi.org/10.1177/0885066616651582).CrossRefPubMed

Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased suicidal risk during long-term lithium treatment: meta-analysis. Bipolar Disord. 2006;8:625–39.PubMedCrossRef

Bauer M, Gitlin M. Treatment of mania with lithium. The essential guide to Lithium Treatment. Basel: Springer International Publishing. 2016;61–70.CrossRef

Bocchetta A, Ardau R, Fanni T, et al. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Med. 2015;13:12.PubMedPubMedCentralCrossRef

Bodén R, Lundgren M, Brandt L, Reutfors J, Andersen M, Kieler H. Risk of adverse pregnancy and birth outcome in woman treated or not treated with mood stabilizers for bipolar disorder: population based cohort study. BMJ. 2012;345. https://doi.org/10.1136/bmj.e7085).

Bone S, Roose SP, Dunner DL, Fieve RR. Incidence of side effects in patients on long-term lithium therapy. Am J Psychiatry. 1980;137:103–4.PubMedCrossRef

Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949;2:349–51.PubMedCrossRef

Chengappa KNR, Chalasani L, Brar JS, Parepally H, Houck P, Levine J. Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, non-randomized chart review. Clin Ther. 2002;24:1576–84.PubMedCrossRef

Chen S, Underwood B, Jones P, Lewis JR, Cardinal RN. Association between lithium use and the incidence of dementia and its subtypes: a retrospective cohort study. PLoS Med. 2022;19(3):e1003941.PubMedPubMedCentralCrossRef

Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378(9799):1306–15.PubMedCrossRef

Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646.PubMedCrossRef

Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162:1805–19.PubMedCrossRef

Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499–507.PubMedCrossRef

Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psych. 2007;68:935–40.CrossRef

Damba J, Bodenstein K, Lavin P, et al. Psychotropic drugs and adverse kidney effects: a systematic review of the past decade of research. CNS Drugs. 2022;36:1049–77.PubMedCrossRef

Davis JM, Janicak PG, Hogan DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand. 1999;100:406–17.PubMedCrossRef

Davis JM. Use of lithium maintenance of unipolar affective disorder. In: Bauer M, Grof P, Müller-Oerlinghausen B, editors. Lithium in neuropsychiatry – the Comprehensive Guide. London-Abingdon: Informa Healthcare; 2006. pp. 99–108.

Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP work group. Clin J Am Soc Nephrol. 2015;10:875–87.PubMedPubMedCentralCrossRef

Dols A, Kessing LV, Strejilevich SA, Rej S, Tsai SY, Gildengers AG, et al. Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report. Int J Geriatric Psychiatry. 2016;31(12):1295–300. https://doi.org/10.1002/gps.4534.

Duce H, Duff C, Zaidi S, Parfitt C, Heald AH, Fryer AA. Evaluation of thyroid function monitoring in people treated with lithium: advice based on real-world data. Int J Bipolar Disord. 2023;5402–9. https://doi.org/10.1111/bdi.13298).

Espanhol JCL, Vieira-Coelho MA. Effects of lithium use on the white matter of patients with bipolar disorder-a systematic review. Nord J Psychiatry. 2022;76:1–11.PubMedCrossRef

Fajardo VA, LeBlanc PJ, MacPherson REK. Examining the relationship between trace lithium in drinking water and the rising rates of age-adjusted Alzheimer’s disease mortality in Texas. J Alzheimers Dis. 2018;61:425–34.PubMedCrossRef

Fitzgerald C, Christensen RHB, Simons J, et al. Effectiveness of medical treatment for bipolar disorder regarding suicide, self-harm and psychiatric hospital admission: between- and within-individual study on Danish national data. Br J Psychiatry. 2022;221:1–9.CrossRef

Forlenza OV, Hajek T, Almeida OP, Beunders AJ, Blumberg HP, Briggs FB, et al. Demographic and clinical characteristics of lithium‐treated older adults with bipolar disorder. Acta Psychiatrica Scandinavica. 2022;146(5):442–55. https://doi.org/10.1111/acps.13474.

Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Br J Psychiatry. 2019;215:668–74.PubMedCrossRef

Fornaro M, Maritan E, Ferranti R, et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry. 2020;177(1):76–92.PubMedCrossRef

Fountoulakis KN, Grunze H, Vieta E, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines. Int J Neuropsychopharmacol. 2017;20:180–95.PubMed

Fransson F, Werneke U, Harju V, et al. Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts. Lancet Psychiatry. 2022;9:804–14.PubMedCrossRef

Gitlin M, Bauer M. Key questions on the long-term renal effects of lithium: a review of pertinent data. Int J Bipolar Disorders. 2023. https://doi.org/10.1186/s40345-023-00316-5.CrossRef

Gitlin MJ, Cochran SD. Jamison KR Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry. 1989;50:127–31.PubMed

Gitlin M. Lithium and the kidney. Drug Saf. 1999;20:231–43.PubMedCrossRef

Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord 2016 4:27 (https://doi.org/10.1186/s40345-016-0068-y).

Gomes-da-Costa S, Marx W, Corponi F, et al. Lithium therapy and weight change in people with bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;134:104266.PubMedCrossRef

Goodwin G, Haddad P, Ferrier I, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016;30:495–553.PubMedPubMedCentralCrossRef

Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013; 154–219.

Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry. 2007;68:380–3.PubMedCrossRef

Hajek T, Bauer M, Pfennig A, et al. Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study. J Psychiatry Neurosci. 2012;37:185–92.PubMedPubMedCentralCrossRef

Hajek T, Bauer M, Simhandl C, Rybakowski J, O’donovan C, Pfennig A, et al. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychological Medicine. 2014;44(3):507–17. https://doi.org/10.1017/S0033291713001165.

Hansen HE, Amdisen A. Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature). Q J Med. 1978;47:123–44.PubMed

Hartigan GP. The use of lithium salts in affective disorders. Br J Psychiatry. 1963;109:810–4.PubMedCrossRef

Haussmann R, Bauer M, von Bonin S, Grof P, Lewitzka U. Treatment of lithium intoxication: facing the need for evidence. Int J Bipolar Disord. 2015;3(23). https://doi.org/10.1186/s40345-015-0040-2).

Hestbech J, Hansen HE, Amdisen A, Olsen S. Chronic renal lesions following long-term treatment with lithium. Kidney Int. 1977;12:205–13.PubMedCrossRef

Hill N, Fatoba S, Oke J, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS ONE. 2016. https://doi.org/10.1371/journal.pone.0158765).CrossRefPubMedPubMedCentral

Hoekstra R, Lekkerkerker MN, Kuijper TM, Bosch TM, van Alphen AM. Renal function after withdrawal of lithium. Bipolar Disord. 2022;24:667–70.PubMedCrossRef

Hozer F, Sarrazin S, Laidi C, et al. Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study. Psychol Med. 2021;51:1201–10.PubMedCrossRef

Huang RY, Hsieh KP, Huang WW, Yang YH. Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study. Br J Psychiatry. 2016;209:393–9.PubMedCrossRef

Hui TP, Kandola A, Shen L, et al. A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder. Acta Psychiatr Scand. 2019;140:94–115.PubMedPubMedCentralCrossRef

Johnson FJ. Handbook of lithium therapy. MTP Press Limited. Edited by Johnson FJ. Lancaster, England. 1980.

Johnson FN. The toxicity panic, in the history of lithium therapy. London, England: Macmillan; 1984. pp. 46–57.

Katz IR, Rogers MP, Lew R, et al. Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a randomized clinical trial. JAMA Psychiatry. 2022;79:24–32.PubMedCrossRef

Kessing L, Gerds TA, Feld-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease. A nationwide population-based study. JAMA Psychiatry. 2015;72:1182–91.PubMedCrossRef

Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disord. 2018. https://doi.org/10.1111/bdi.12623).CrossRefPubMed

Kessing LV, Gerds TA, Knudsen NN, et al. Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry. 2017b;74:1005–10.PubMedPubMedCentralCrossRef

Kessing LV, Gerds TA, Knudsen NN, Jørgensen LF, Kristiansen SM, Voutchkova D, et al. Lithium in drinking water and the incidence of bipolar disorder: a nation‐wide population‐based study. Bipolar Disorders. 2017a;19(7):563–67. https://doi.org/10.1111/bdi.12524.

Kessing LV, Knudsen MB, Rytgaard HC, Torp-Pedersen C, Berk M. Lithium versus anticonvulsants and the risk of physical disorders–Results from a comprehensive long-term nation-wide population-based study emulating a target trial. European Neuropsychopharmacology. 2024;84:48–56. https://doi.org/10.1016/j.euroneuro.2024.04.009.

Kessing LV, Søndergård L, Kvist K, Andersen PK. Suicide risk in patients treated with lithium. Arch Gen Psychiatry. 2005;62:860–6.PubMedCrossRef

Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 2016;18:174–82.PubMedCrossRef

Kibrige D, Luzinda K, Ssekitoleko R. Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res. 2013; 6(3).

Kleiner J, Altshuler L, Hendrick V, Hershman JM. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry. 1999;60:249–55.PubMedCrossRef

Kosten TR, Forrest JN. Treatment of severe lithium-induced polyuria with amiloride. Am J Psychiatry. 1986;143:1563–8.PubMedCrossRef

Kovacs Z, Vestergaard P, W. Licht R, PV Straszek S, Hansen AS, H. Young A, et al. Lithium induced hypercalcemia: an expert opinion and management algorithm. Int J Bipolar Disorders. 2022;10(1):34. https://doi.org/10.1186/s40345-022-00283-3.

Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. 6. Auflage. Leipzig: Barth, 1899.

Lange C. Om Periodiske Depressionstilstande og deres Patogenese [On Periodical Depressions and their Pathogenesis]. Copenhagen: Jacob Lunds Forlag, 1895 (2nd edition).

Lauterbach E, Felber W, Müller-Oerlinghausen B, et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand. 2008;118:469–79.PubMedCrossRef

Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23:723–33.PubMedCrossRef

Liu X, Verma A, Garcia G Jr, et al. Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition. Proc Natl Acad Sci U S A. 2021;118(42):e2113401118.PubMedPubMedCentralCrossRef

Lucini-Paioni S, Squarcina L, Cousins DA, Brambilla P. Lithium effects on Hippocampus volumes in patients with bipolar disorder. J Affect Disord. 2021;294:521–6.PubMedCrossRef

Malhi GS, Bell E, Jadidi M, Gitlin MJ, Bauer M. Countering the declining use of lithium therapy: a call to arms. Int J Bipolar Disord. 2023;11(1):30.PubMedPubMedCentralCrossRef

Malhi GS, Tanious M, Das P, Coulston CM, Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs. 2013;27:135–53.PubMedCrossRef

Matsunaga S, Kishi T, Annas P, Basun H, Hampel H, Iwata N. Lithium as a treatment for Alzheimer’s Disease: a systematic review and Meta-analysis. J Alzheimers Dis. 2015;48:403–10.PubMedCrossRef

McIntyre RS, Kwan ATH, Rosenblat JD, Teopiz KM, Mansur RB. Psychotropic drug-related WeightGain and its treatment. Am J Psychiatry. 2024;181:26–38.PubMedCrossRef

Meehan AD, Humble MB, Yazarloo P, Jӓrhult J, Wallin G. The prevalence of lithium-associated hyperparathyroidism in a large Swedish population attending psychiatric outpatient units. J Clin Psychopharmacol. 2015;35(3):279–85.PubMedCrossRef

Meehan AD, Wallin G, Järhult J. Characterization of calcium homeostasis in lithium-treated patients reveals both hypercalcaemia and hypocalcaemia. World J Surg. 2020;44(2):517–25.PubMedCrossRef

Memon A, Rogers I, Fitzsimmons SMDD, et al. Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies. Br J Psychiatry. 2020;217:667–78.PubMedCrossRef

Misfud S, Cilia K, Mifsud E, Gruppetta M. Lithium-associated hyperparathyroidism. Br J Hosp Med. 2020;81:1–9. https://doi.org/10.12968/hmed.2020.0457).CrossRef

Miura T, Noma H, Furukawa TA, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1:351–9.PubMedCrossRef

Müller-Oerlinghausen B, Lewitzka U. Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology. 2010;62:43–9.PubMedCrossRef

Molenaar NM, Poels EM, Robakis T, Wesseloo R, Bergink V. Management of lithium dosing around delivery: an observational study. Bipolar Disord. 2021;23:49–54.PubMedCrossRef

Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356(9237):1241–2.PubMedCrossRef

Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual report of the American association of poison control centers’ national poison data system (NPDS): 30th annual report. Clin Toxicol (Phila). 2013;51:949–1229.

Murru A, Manchia M, Hajek T, et al. Lithium’s antiviral effects: a potential drug for CoViD-19 disease? Int J Bipolar Disord. 2020;8:21.PubMedPubMedCentralCrossRef

Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression. J Affect Disord. 2014;168:269–75.PubMedCrossRef

Nemeth EF. The search for calcium receptor antagonists (calcilytics). J Mol Endocrinol. 2002;29:15–21.PubMedCrossRef

Nielsen RE, Kessing LV, Nolen WA, Licht RW. Lithium and renal impairment: a review on a still hot topic. Pharmacopsychiatry. 2018;51(05):200–05. https://doi.org/10.1055/s-0043-125393.

Nivoli AM, Murru A, Goikolea JM, et al. New treatment guidelines for acute bipolar mania: a critical review. J Affect Disord. 2012;140:125–41.PubMedCrossRef

Nolen W, Licht R, Young A, et al. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Int J Bipolar Disord. 2019;21:394–409.CrossRef

Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer’s disease in elderly patients with bipolar disorder. Br J Psychiatry. 2007;190:359–60.PubMedCrossRef

Ott M, Stegmayr B, Salander RE, Werneke U. Lithium intoxication: incidence, clinical course and renal function-a population-based retrospective cohort study. J Psychopharmacol. 2016. https://doi.org/10.1177/0269881116652577).CrossRefPubMedPubMedCentral

Patorno E, Huybrechts KF, Bateman BT, et al. Lithium use in pregnancy and risk of cardiac malformation. N Engl J Med. 2017;376:2245–54.PubMedPubMedCentralCrossRef

Perrone J, Mudan A. Lithium poisoning. UpToDate. 2022.

Pichler EM, Fartacek C, Miller-Doebeling B, Walter M, Plöderl M. Too early to add lithium to drinking water? No association between lithium and suicides in a pre-registered Swiss study. J Affective Disorders. 2024;367:598–605. https://doi.org/10.1016/j.jad.2024.08.239.

Plenge P, Mellerup ET, Bolwig TG, et al. Lithium treatment: does the kidney prefer one daily does instead of two? Acta Psychiatr Scan. 1982;66:121–8.CrossRef

Poels EMP, Schrijver L, White TJH, et al. The effect of prenatal lithium exposure on the neuropsychological development of the child. Bipolar Disord. 2022;24:310–9.PubMedCrossRef

Rhee TG, Olfson M, Nierenberg AA, Wilkinson ST. 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrist in outpatient care settings. Am J Psychiatry. 2020;177:706–15.PubMedPubMedCentralCrossRef

Rusner M, Berg M, Begley C. Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes. BMC Pregnancy Childbirth. 2016;16:331. https://doi.org/10.1186/s12884-016-1127-1).CrossRefPubMedPubMedCentral

Schioldann J. On periodical depressions and their pathogenesis’ by Carl Lange (1886). Hist Psychiatry. 2011;22(85 Pt 1):108–30.PubMedCrossRef

Schorestsanitis G, Filippis R, Brady B, Homan P, Suppes T, Kane JM. Prevalence of impaired kidney function in patients with long-term lithium treatment: a systemic review and meta-analysis. Bipolar Disord. 2021;24:264–74.CrossRef

Schou M, Juel-Nielsen N, Strömgren E, et al. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiat. 1954;17:250–60.PubMedPubMedCentralCrossRef

Schou M. Lithium in psychiatric therapy and prophylaxis. J Psych Res. 1968;6:67–95.CrossRef

Severus E, Taylor MJ, Sauer C, et al. Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord. 2014;2:15. https://doi.org/10.1186/s40345-014-0015-8).CrossRefPubMedPubMedCentral

Shaw ED, Mann JJ, Stokes PE, Manevitz AZ. Effects of lithium carbonate on associative productivity and idiosyncrasy in bipolar outpatients. Am J Psych. 1986;67:1698–706.

Shorter E. The history of lithium therapy. Bipolar Disord. 2009;11(Suppl 2):4–9.PubMedPubMedCentralCrossRef

Shulman KI, Almeida OP, Herrmann N, Schaffer A, Strejilevich SA, Paternoster C, et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: an ISBD task force report. Bipolar Disorders. 2019;21(2):117–23. https://doi.org/10.1111/bdi.12714.

Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry. 1991;158:666–75.PubMedCrossRef

Spatola L, Maringhini S, Canale C, Granata A, D’Amico M. Lithium poisoning and renal replacement therapy: pathophysiology and current clinical recommendations. Int Urol Nephrol. 2023;55:2501–5.PubMedCrossRef

Staudt-Hansen P, Frahm Laursen M, Grøntved S, Vogt Straszek SP, Licht RW, Nielsen RE. Increasing mortality gap for patients diagnosed with bipolar disorder-A nationwide study with 20 years of follow-up. Bipolar Disord. 2019;21:270–5.PubMedCrossRef

Stewart DE. Depression during pregnancy. N Engl J Med. 2011;365:1605–11.PubMedCrossRef

Strawbridge R, Kerr-Gaffney J, Bessa G, et al. Identifying the neuropsychiatric health effects of low-dose lithium interventions: a systematic review. Neurosci Biobehav Rev. 2023;144:104975.PubMedCrossRef

Tondo L, Abramowicz M, Alda M, et al. Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disorders. 2017;5:27. https://doi.org/10.1186/s40345-017-0096-2).CrossRef

Tondo L, Alda M, Bauer M, et al. Clinical use of lithium salts: guide for users and prescribers. International Group for Studies of Lithium (IGSLi). Int J Bipolar Disord. 2019;7:16. https://doi.org/10.1186/s40345-019-0151-2).CrossRefPubMedPubMedCentral

Tondo L, Baldessarini RJ. Prevention of suicidal behavior in bipolar disorder patients with lithium treatment. Int J Bipolar Disord. 2024;12:6.PubMedPubMedCentralCrossRef

Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand. 2001;104:163–72.PubMedCrossRef

Van Alphen A, Bosch T, Kupka R, Hoekstra R. Chronic kidney disease in lithium-treated patients, incidence and rate of decline. Int J Bipolar Disorders. 2021;9:1. https://doi.org/10.1186/s40345-020-00204-2).CrossRef

Vestergaard P, Amdisen A, Schou M. Clinically significant side effects of lithium treatment. Acta Psychiatr Scand. 1980;62:193–200.PubMedCrossRef

Vestergaard P, Mollerup CL, Frøkjær VG, Christiansen PM, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ. 2000;321(7261):598–602.PubMedPubMedCentralCrossRef

Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179–84.PubMedCrossRef

Viguera AC, Tondo L, Koukopouloous AE, Reginaldi D, Lepri B, Baldessarini RJ. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry. 2011;168:1179–85.PubMedCrossRef

Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164:1817–24.PubMedCrossRef

Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age-and gender-specific reference values of estimated GFR in caucasians: the Nijmegen Biomedical Study. Kidney Int. 2007;72:632–7. https://doi.org/10.1038/sj.ki.5002374).CrossRefPubMed

Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive performance: a meta-analysis. J clin Psychiatry. 2009;70:1588–97.PubMedCrossRef

Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and anxiety treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97–170.PubMedPubMedCentralCrossRef

Yildiz A, Vieta E, Leucht S, Baldessarini RJ. Efficacy of antimanic treatments: Meta-analysis of randomized, controlled trials. Neuropsychopharmacol. 2011;36:375–89.CrossRef

Young AH, McElroy SL, Bauer M, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression. Embolden I (trial 001) investigators. J Clin Psychiatry. 2010;71:150–62.PubMedCrossRef

Title: Lithium: current state of the art and future directions
Authors: Michael Gitlin
Michael Bauer
Publication date: 01-12-2024
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Bipolar Disorders / Issue 1/2024
Electronic ISSN: 2194-7511
DOI: https://doi.org/10.1186/s40345-024-00362-7

Relevance of red blood cell Lithium concentration in the management of Lithium-treated bipolar and unipolar disorders: a systematic narrative review

Open Access
Brief Report

Cognitive behavioural therapy for social anxiety disorder in people with bipolar disorder: a case series

Open Access
Social Anxiety Disorder
Research

Prevention of suicidal behavior with lithium treatment in patients with recurrent mood disorders

Open Access
Suicide
Review

Type of cycle, temperament and childhood trauma are associated with lithium response in patients with bipolar disorders

Open Access
Research

Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal trial

Open Access
Research

Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol

Open Access
Biomarkers
Study Protocol

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Advances in Alzheimer's

Alzheimer's Disease
Independent Medical Education

Alzheimer's research and care is changing rapidly. Keep up with the latest developments from key international conferences, together with expert insights on how to integrate these advances into practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:

Lilly

Developed by: Springer Healthcare IME

Learn more